Data from the NOA-04 trial demonstrated the positive predictive value of MGMT promotor methylation in IDHwt astrocytomas WHO grade III but did not test for molecular features of glioblastoma like TERT promotor mutation [6]. Here, MGMT is linked to astrocytoma (excluding glioblastoma).